TP53 and neoplasm: While our data indicate that increased p53 expression using APR-246 augments the effects of ICB by reprograming the TME, it was unclear whether this mechanism of action was a direct consequence of increased p53 expression in the immune compartment of the TME independently from its activity on the tumor cells.